共查询到20条相似文献,搜索用时 93 毫秒
1.
目的 探讨涎腺黏液表皮样癌(mucoepidermoid carcinoma,MEC)热休克蛋白(HSP)60表达及其与微血管密度间的关系.方法 应用免疫组织化学方法检测46例MEC患者HSP60和微血管密度(microvessel density,MVD)的表达,并将检测结果与临床资料进行统计分析.结果 HSP60在MEC中表达的强弱与癌组织的分化程度有关(P<0.05),而与患者的性别、年龄无关.MEC MVD与其分化程度及淋巴结转移有关(P<0.01),而与患者的性别、年龄无关.结论 HSP60表达水平及MVD与MEC组织的分化程度和转移相关,为临床建立新的MEC预后预测因子和指导临床治疗提供依据. 相似文献
2.
目的 探讨Ⅳ型胶原表达与涎腺黏液表皮样癌(Mucoepidermoid carcinoma,MEC)临床病理的关系及其与微血管密度之间的联系.方法 应用免疫组织化学方法,检测46例MEC患者内Ⅳ型胶原表达与微血管密度(Microvessel density,MVD),并将检测结果与患者的临床资料进行统计分析.结果 Ⅳ型胶原在涎腺黏液表皮样癌中表达的强弱与癌组织的分化程度及淋巴结转移有关(P<0.05),而与患者的性别、年龄无关(P>0.05).涎腺黏液表皮样癌的MVD与其分化程度及淋巴结转移有关(P<0.01),而与患者的性别、年龄无关(P>0.05).结论 Ⅳ型胶原表达水平及MVD与涎腺黏液表皮样癌组织的分化程度和转移相关. 相似文献
3.
目的探讨Ⅳ型胶原表达与涎腺黏液表皮样癌(Mucoepidermoid carcinoma,MEC)临床病理的关系及其和微血管密度之间的联系。方法应用免疫组织化学方法,检测46例MEC内Ⅳ型胶原表达与微血管密度(Microvessel density,MVD),并将检测结果进行统计分析。结果Ⅳ型胶原在涎腺黏液表皮样癌中表达的强弱与癌组织的分化程度及淋巴结转移有关(P<0.05),而与患者的性别、年龄无关(P>0.05)。涎腺黏液表皮样癌的MVD与其分化程度及淋巴结转移有关(P<0.01),而与患者的性别、年龄无关(P>0.05)。结论Ⅳ型胶原表达水平及MVD与涎腺黏液表皮样癌组织的分化程度和转移相关,此结果为临床建立新的MEC预后预测因子和指导临床治疗提供依据。 相似文献
4.
目的 观察缺氧诱导因子-1α(HIF-1α)、血管内皮生长因子(VEGF)及微血管密度(MVD)在涎腺腺样囊性癌(SACC)组织中的表达变化,并探讨其意义.方法 采用免疫组化SP法检测46例SACC及5例正常涎腺组织中的HIF-1α、VEGF及CD105,计算MVD.结果 SACC组织中HIF-1α阳性表达率为47.8%(22/46)、VEGF为65.2%(30/46)、MVD为(31.50±4.87)条/HP,正常涎腺组织均为阴性,两者相比,P均<0.05;HIF-1α、VEGF的表达及MVD值与SACC临床病理分型、TNM分期有关(P均<0.05),HIF-1α与VEGF的表达呈正相关(r=0.472,P<0.01)、与MVD呈正相关(r=0.431,P<0.01).结论 SACC组织中HIF-1α、VEGF、MVD表达上调,可作为判断SACC生物学行为及预后的指标. 相似文献
5.
目的观察survivin和livin在涎腺腺样囊性癌(SACC)组织中的表达变化,并探讨其意义。方法采用免疫组化SP法检测42例SACC及6例正常涎腺组织中的survivin和livin。结果 SACC组织中survivin、livin阳性表达率分别为69.0%(29/42)、59.5%(25/42),正常涎腺组织均为阴性,两者相比,P均〈0.05;SACC中survivin的表达与淋巴结转移相关(P〈0.05),livin的表达与临床病理分期、淋巴结转移相关(P均〈0.05)。结论 SACC组织中survivin和livin的表达上调,与SACC的预后有关。 相似文献
6.
目的观察涎腺腺样囊性癌(SACC)组织中survivin、环氧化酶-2(COX-2)的表达变化,并探讨其临床意义。方法采用免疫组化法检测42例SACC及22例正常涎腺组织中的survivin、COX.2蛋白。结果SACC组织中survivin、COX-2蛋白阳性率分别为59.5%(25/42)、64.3%(27/42),正常涎腺组织中分别为0、4.5%;两者比较,P均〈0.05。SACC组织TNM分期Ⅲ~Ⅳ期survivin、COX-2蛋白阳性率分别为84.6%(11/13)、84.6%(11/13),显著高于Ⅰ~Ⅱ期的48.2%(14/29)、55.1%(16/29),P均〈0.05。相关分析显示,SACC组织中survivin、COX-2蛋白表达呈正相关(r=0.832,P〈0.05)。结论SACC组织中COX-2、survivin高表达,二者在SACC发生、发展中发挥重要作用。 相似文献
7.
8.
9.
10.
11.
研究肝细胞肝癌(Hepatocellular Carcinoma,HCC)微血管密度(Microvessel Density,MVD)与雌激素受体(Estrogen Receptor,ER)表达之间的关系,以及此二者与临床病理学特征之间的关系.36例HCC的患者分为ER(+)组和ER(-)组.按MVD值分为MVD<中位值组和MVD>中位值组,比较各组有预后意义的临床病理学参数之间的差别.ER(+)14例,ER(-)22例.全组MVD自3至121(44.67±32.15中位值为36).ER(+)的HCC为直径较小、多有完整的包膜和较低的血清AFP浓度.MVD较低的HCC多为单结节、直径较小、细胞分化较好、血清AFP浓度较低.ER含量与MVD呈负相关.由此可见(1)ER(+)或MVD较低的HCC分别比ER(-)或MVD较高的HCC恶性度较低.(2)ER与MVD均是有价值的预后指标. 相似文献
12.
5-脂氧合酶mRNA在食管鳞癌中的表达及与血管生成的关系 总被引:2,自引:0,他引:2
目的探讨5-脂氧合酶(5-LOX)和微血管密度(MVD)在食管鳞状上皮细胞癌(ESCC)组织中的表达及相关关系,及5-LOX与肿瘤浸润和转移的关系。方法用半定量RT-PCR法测定35例ESCC患者癌组织(T)和相邻癌旁组织(N)中5-LOX mRNA的表达,求得T/N值。同时用免疫组织化学法测定癌组织和癌旁正常组织中微血管密度(MVD)的T/N值。结果在35例ESCC患者中,33例5-LOX mRNA的T/N值〉1.0,占94.3%,34例MVD的T/N值〉1.0,占97.1%。5-LOX mRNA和MVD与食管鳞癌的肿瘤大小、浸润深度和淋巴结转移、肿瘤分化程度有关。5-LOX mRNA的T/N值与MVD的T/N值呈正相关。结论5-LOX与食管鳞癌血管生成和肿瘤浸润转移密切相关,其高表达可能促进肿瘤血管生成,从而促进ESCC的浸润和转移。 相似文献
13.
14.
15.
Hepatocellular carcinoma (HCC) is a severe type of primary liver cancer with high postoperative recurrence. The prognosis predictability of tumor-infiltrating leukocytes (TILs) for patients who underwent HCC resection has been widely reported. However, limited information is available about TIL trafficking, which is also crucial for HCC patients.We included tumor tissue samples and clinical data from 89 HCC patients in this study and performed immunohistochemistry for CD3, CD8, FoxP3, and CD31. TILs were measured using an algorithm for quantification of tumor immune stroma (QTiS). Intratumoral microvessels were counted using Weidner''s method. We first examined correlations among them and analyzed their relationships with clinical and survival data.Intratumoral microvessel density (iMVD) was significantly correlated with infiltration of CD3+ (r = 0.338, P = .001) and CD8+ (r = 0.320, P = .002) cells, but not FoxP3+ (r = 0.153, P = .152) cells. After multivariate analysis, higher infiltration of CD3+ (P = .038) independently showed significant predictability on better overall survival after resection of HCC. Although no influence of CD3+ (P = .386) and CD8+ (P = .648) cells were found on general disease-free survival, infiltration of CD3+ (P = .012), tumor size (P = .032) and albumin (P = .007) cells independently predicted late-phase disease-free survival. No significant relationships regarding iMVD, and infiltration of FoxP3+ cells with overall and disease-free survival were found.Our data suggest that increased iMVD could enrich tumor-infiltrating CD3+ cells. Infiltrated CD3+ cells could help to better predict both the overall and late-phase disease-free survival after resection of HCC. 相似文献
16.
17.
18.
目的:探讨真核翻译起始因子-5A2(eukaryotic initiation factor 5A2,EIF-5A2)在肝癌内的表达及其与VEGF表达、血管密度和临床病理指标的关系.方法:用免疫组织化学方法检测49例HCC组织及6例正常肝组织中EIF-5A2、VEGF和CD34的表达,计数微血管密度(MVD),并结合临床病理特征进行比较分析.结果:49例HCC组织中EIF-5A2、VEGF、CD34阳性表达率分别为87.7%、89.7%及100.0%,正常肝组织EIF-5A2、CD34表达呈阴性,VEGF表达为阴性或弱阳性.肝癌组织中EIF-5A2蛋白表达与VEGF表达及MVD间均呈正相关(r=0.416,0.321,均P<0.05);不同肿瘤灶数量的HCC组织EIF-5A2、VEGF蛋白表达及MVD差别无显著性,不同直径HCC的EIF-5A2、VEGF蛋白表达差别亦无显著性,而不同直径的HCC的MVD差别有显著性(P<0.05).有癌栓形成组与无癌栓组相比EIF-5A2、VEGF蛋白表达及MVD差别均有显著性(均P<0.05).肿瘤包膜完整组与无胞膜/包膜不完整组两组间EIF-5A2、VEGF蛋白表达及MVD差别均有显著性(均P<0.05).结论:肝癌组织中有较高的EIF-5A2阳性表达;EIF-5A2表达与VEGF表达及MVD呈正相关,与HCC组织血管侵犯和转移倾向有关. 相似文献
19.
目的 提高对原发性肺黏液表皮样癌的认识.方法 结合1例原发性黏液表皮样癌患者的临床资料,搜集13篇国内文献的199例患者的临床资料以及复习国内外相关文献,分析、归纳该病的临床表现、影像学特点、病理学特征、诊断及鉴别诊断、治疗及预后.结果 原发性肺黏液表皮样癌的临床症状为咳嗽、咳痰、胸闷、胸痛,但症状缺乏特异性.胸片常显示出肺不张或肺炎,CT主要表现为光滑分叶状或息肉状肿块伴远端支气管黏液嵌塞和肺不张.病理学检查主要特征是可见不同比例的黏液分泌细胞、鳞状表皮样细胞以及中间型细胞组成,未见角化.治疗首选手术,放、化疗治疗效果目前没有得到肯定.预后相较于传统的非小细胞肺癌更好.结论 原发性肺黏液表皮样癌罕见,容易误诊,应充分认识该病的有关特点,提高疗效,改善预后. 相似文献
20.
Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma 总被引:1,自引:0,他引:1
Yan G Zhou XY Cai SJ Zhang GH Peng JJ Du X 《World journal of gastroenterology : WJG》2008,14(1):101-107
AIM: To investigate the distribution pattern of lymphatic vessels and microvessels in sporadic colorectal carcinoma (SCRC) and their relationship to metastasis and prognosis. METHODS: The lymphatic vessel density (LVD) and microvessel density (MVD) in tumor tissue obtained from 132 patients with primary SCRC, including 74 with metastases and 58 without metastases, were evaluated by immunohistochemistry using antibodies directed against D2-40 and yon Willebrand factor (vWF). RESULTS: (1) The lymphatic vessels and microvessels at central portions of SCRC often had a reticular architecture with numerous tiny and ill-defined lumina, while those at tumor borders had large and open lumina. The LVD and MVD were both obviously higher in colorectal cancer patients with metastases than in those without (P 〈 0.001). (2) For each one lymphatic vessel increased, there was a 1.45-fold increase in the risk of metastasis in SCRC. The specificity and sensitivity of LVD in predicting metastasis or non-metastasis in SCRC were 71.62% and 56.90%, respectively, and the corresponding LVD was 5. For each one microvessel increased, there was a 1.11-fold increase in the risk of metastasis in SCRC. The specificity and sensitivity of MVD were 66.22% and 51.72%, respectively. (3) Double labeling immunohistochemistry showed D2-40 immunoreactivity to be specific for lymphatic vessels. (4) Univariate analysis indicated that high LVD, high MVD, as well as co-accounting of high LVD and high MVD were associated with patient's poor disease-free survival (Puni 〈 0.05); multivariate analysis indicated that co-accounting of LVD and MVD was an independent prognostic factor of colorectal cancer, CONCLUSION: D2-40 is a new specific antibody for lymphatic endothelial cells. Lymphogenesis and angiogenesis are commonly seen in SCRC, especially at tumor borders. The detection of LVD and MVD at tumor borders may be useful in predicting metastasis and prognosis in patients with SCRC, and, in particular, coa 相似文献